Delivery Order SPE2DB24D2205-SPE2DB25FDWMK

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 100 capsules of the drug Tacrolimus 1 mg (immediate release) to the Defense Logistics Agency (DLA). The firm-fixed-price, $1,420.57 delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a wide range of...
This federal contract award, valued at $1,550.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tacrolimus 1 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,095.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, a specialized medication. This is a firm fixed-price delivery order with a completion date of October 17, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $3,029.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,566,779,420 units of Tacrolimus 1 mg capsules, an immunosuppressant medication. The contract has a completion date of December 23, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFGYT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,514.52 firm fixed-price delivery order is for the supply of 100 capsules of the drug Tacrolimus 1 mg, an immunosuppressant medication. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,310.40 for the supply of Tacrolimus 1 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating an open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,412.10 firm fixed-price delivery order is for Tacrolimus 1 mg capsules, with an ultimate completion date of October 28, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,831.34 delivery order is for 100 capsules of the prescription drug Tacrolimus 1 mg, an immunosuppressant medication. The contract is a firm-fixed price Delivery Order with a completion date of December 30, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,058.08 firm fixed-price delivery order contract is for the supply of 100 capsules of 1 mg Tacrolimus, an immunosuppressant medication, to support federal healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tacrolimus 5 mg capsules (immediate release) in 100-count units. The $3,871.10 contract is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDWMK
    Delivery Order

This federal contract award, valued at $27,214.66, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 100 capsules of the medication Tacrolimus 5 mg, with a period of performance through January 7, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical through November 2026 and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/7/25, 10:49 AM